Behavioral and Psychological Symptoms of Dementia
Top Cited Papers
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 3, 73
- https://doi.org/10.3389/fneur.2012.00073
Abstract
Behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms, represent a heterogeneous group of non-cognitive symptoms and behaviors occurring in subjects with dementia. BPSD constitute a major component of the dementia syndrome irrespective of its subtype. They are as clinically relevant as cognitive symptoms as they strongly correlate with the degree of functional and cognitive impairment. BPSD include agitation, aberrant motor behavior, anxiety, elation, irritability, depression, apathy, disinhibition, delusions, hallucinations, and sleep or appetite changes. It is estimated that BPSD affect up to 90% of all dementia subjects over the course of their illness, and is independently associated with poor outcomes, including distress among patients and caregivers, long-term hospitalization, misuse of medication, and increased health care costs. Although these symptoms can be present individually it is more common that various psychopathological features co-occur simultaneously in the same patient. Thus, categorization of BPSD in clusters taking into account their natural course, prognosis, and treatment response may be useful in the clinical practice. The pathogenesis of BPSD has not been clearly delineated but it is probably the result of a complex interplay of psychological, social, and biological factors. Recent studies have emphasized the role of neurochemical, neuropathological, and genetic factors underlying the clinical manifestations of BPSD. A high degree of clinical expertise is crucial to appropriately recognize and manage the neuropsychiatric symptoms in a patient with dementia. Combination of non-pharmacological and careful use of pharmacological interventions is the recommended therapeutic for managing BPSD. Given the modest efficacy of current strategies, there is an urgent need to identify novel pharmacological targets and develop new non-pharmacological approaches to improve the adverse outcomes associated with BPSD.Keywords
This publication has 101 references indexed in Scilit:
- Structural Correlates of Apathy in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2007
- International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementiaInternational Psychogeriatrics, 2007
- The Progression of Cognition, Psychiatric Symptoms, and Functional Abilities in Dementia With Lewy Bodies and Alzheimer DiseaseArchives of Neurology, 2006
- Behavioral correlates of GABAergic disruption in Alzheimer's diseaseInternational Psychogeriatrics, 2006
- Systematic Review of Psychological Approaches to the Management of Neuropsychiatric Symptoms of DementiaAmerican Journal of Psychiatry, 2005
- Components of behavioral pathology in dementiaInternational Journal of Geriatric Psychiatry, 2005
- Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy BodiesAmerican Journal of Psychiatry, 2004
- The persistence of neuropsychiatric symptoms in dementia: the Cache County StudyInternational Journal of Geriatric Psychiatry, 2004
- Delusional Thoughts and Regional Frontal/Temporal Cortex Metabolism in Alzheimer’s DiseaseAmerican Journal of Psychiatry, 2003
- Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s DiseaseStroke, 2000